Citius Oncology, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0537b0a3-1f17-44e8-ac56-ffeb41f959d0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-24.8M | 2024-10-01 – 2025-09-30 | evidence 0001213900-25-125331 |
| FY 2024 | $-21.1M | 2023-10-01 – 2024-09-30 | evidence 0001213900-24-113150 |
| FY 2023 | $2.4M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-014850 |
| FY 2022 | $380.8k | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-012545 |
| FY 2021 | $-10.1k | 2021-03-01 – 2021-12-31 | evidence 0001493152-23-012545 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).